Assessing the prediction accuracy of a cure model for censored survival data with long-term survivors: Application to breast cancer data

The Cox proportional hazards cure model is a survival model incorporating a cure rate with the assumption that the population contains both uncured and cured individuals. It contains a logistic regression for the cure rate, and a Cox regression to estimate the hazard for uncured patients. A single p...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of biopharmaceutical statistics 2017-11, Vol.27 (6), p.918-932
Hauptverfasser: Asano, Junichi, Hirakawa, Akihiro
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Cox proportional hazards cure model is a survival model incorporating a cure rate with the assumption that the population contains both uncured and cured individuals. It contains a logistic regression for the cure rate, and a Cox regression to estimate the hazard for uncured patients. A single predictive model for both the cure and hazard can be developed by using a cure model that simultaneously predicts the cure rate and hazards for uncured patients; however, model selection is a challenge because of the lack of a measure for quantifying the predictive accuracy of a cure model. Recently, we developed an area under the receiver operating characteristic curve (AUC) for determining the cure rate in a cure model (Asano et al., 2014), but the hazards measure for uncured patients was not resolved. In this article, we propose novel C-statistics that are weighted by the patients' cure status (i.e., cured, uncured, or censored cases) for the cure model. The operating characteristics of the proposed C-statistics and their confidence interval were examined by simulation analyses. We also illustrate methods for predictive model selection and for further interpretation of variables using the proposed AUCs and C-statistics via application to breast cancer data.
ISSN:1054-3406
1520-5711
DOI:10.1080/10543406.2017.1293082